medigraphic.com

2003, Número s1

<< Anterior Siguiente >>

Arch Cardiol Mex 2003; 73 (s1)


Evaluación ecocardiográfica de la insuficiencia cardíaca

Guadalajara BJF

Idioma: Español
Referencias bibliográficas: 38
Paginas: 53-59
Archivo PDF: 140.03 Kb.


RESUMEN

El Ecocardiograma es un procedimiento de fácil acceso para el estudio del paciente cardiópata. Específicamente es de gran utilidad para establecer el diagnóstico de insuficiencia cardíaca y diferenciarlo de otras entidades que producen manifestaciones clínicas similares, pero que su pronóstico y tratamiento son distintos. Ya establecido el diagnóstico, con certeza se pueden obtener otros parámetros, como la fracción de expulsión, la masa ventricular, relación masa/volumen, relación grosor/radio (h/r), dP/dT del ventrículo izquierdo con Doppler continuo y el registro del flujo transmitral mediante Doppler pulsado. Todos ellos, no sólo cuantifican el grado de insuficiencia cardíaca en el paciente, sino que también tienen implicaciones pronósticas.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Weber KT, Brilla GG: Pathological hypertrophy and cardiac interstitium: Fibrosis and renin-angiotensin-aldosterone system. Circulation 1991; 83: 1849-1865.

  2. The multicenter post infarction research group: Risk stratification and survival after myocardial infarction. N Engl J Med 1983; 309: 331-336.

  3. Katz A: Cardiomyopathy of overload. Major determinant of prognosis in congestive heart failure. N Engl J Med 1990; 322: 100-110.

  4. Schwartz RG, McKenzie WB, Alexander J: Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven years experience using serial radionuclide angiocardiography. Am J Med 1987; 82: 1109-1116.

  5. Schulze K, Becker BF, Schamer R, Shawer R, Schultheiss HP: Antibodies to the ADP/ATP carrier an autoantigen in myocarditis and dilated cardiomyopathy-Impair cardiac function. Circulation 1990; 81: 959-969.

  6. Leiden JM: The genetics of dilated cardiomyopathy-emerging clues to the puzzle. N Engl J Med 1997; 337: 1080-1081.

  7. Stewart S, MactIntyre K, Hole DJ: More malignant than cancer? Five year survival following a first admission for heart failure. Eur J Heart Fail 2001; 3: 315-322.

  8. Smith WM: Epidemiology of congestive heart failure. Am J Cardiol 1985; 55(Suppl A): 3A-8A.

  9. Ho KKL, Pinsky JL, Kannel WB: The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol 1993; 22(Suppl A): 6A-13A.

  10. Pfeffer MA, Braunwald E: Ventricular Remodeling after myocardial infarction: experimental observation and clinical implications. Circulation 1990; 81: 1161-1172.

  11. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ, Cuddy TE, et al: The effect of captopril on mortality with left ventricular dysfunction following myocardial infarction: results of the survival and ventricular enlargement (SAVE) trial. N Engl J Med 1992; 327: 669-677.

  12. The SOLVD Investigators: Effect of enalapril on mortality and the development of heat failure in asymptomatic patients with reduced left ventricular ejection fraction. N Engl J Med 1992; 337: 685-691.

  13. Bristow M, Gilbert EM, Abraham WT, Adams KF, Fowler MB, Hershberger RE, et al: MOCHA investigators carvedilol produces dose-related improvement in left ventricular function an survival in subjects with chronic heart failure. Circulation 1996; 94: 2807-2816.

  14. Simon T, Mary-Krause M, Furnk-Brentano C, Lechat Ph, Jaillon P: Bisoprolol dose-response relationhip in patients with congestive heart failure: a subgroup analysis ice the cardiac insufficiency bisoprolol study. Eur Heart J 2003; 24: 1-8.

  15. Cazeau S, Leclerc C, Levergne T, Walter S, Varma Ch, Lind C, et al: Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001: 344; 873-880.

  16. Glikso M, Friedman PA: The implantable cardioverter defibrillator. Lancet 2001; 357: 1107-1117.

  17. Gómez JA, Carambas CR, Natthews LM, Moran HE, Damato AN: Inotropic effect of post-stimulation in man. An Echocardiographic study. Am J Cardiol 1979; 43: 745-752.

  18. Schiller N, Shah P, Crawford M, DeMaria A, Devereaux R, Feigembaun H, et al: Recommendations for quantitation of the left ventricle by two dimensional echocardiography: American Society of Echocardiography Committee on Standards Subcommittee on Quantitation of two Dimensional Echocardiography. Am J Soc Echocard 1989; 2: 358-367.

  19. Schwartz F, Mall G, Zebe H, Schmitzer E, Manthey J, Scheurlen H, Kubler W: Determinants of survival in patients with congestive cardiomyopathy: quantitative morphologies findings and left ventricular hemodynamics. Circulation 1984; 70: 923-928.

  20. Grossman W: Cardiac hypertrophy: useful adaptation or pathologic process. Am J Med 1980; 69: 576-583.

  21. Gaash WH: Left ventricular radius to wall thickness ratio. Am J Cardiol 1979; 43: 1189-1194.

  22. Field BJ, Baxley WA, Rossell RO, Hood WP, Holt JH, Dowling JT, Rackley CE: Left ventricular function and hypertrophy in cardiomyopathy with depressed ejection fraction. Circulation 1973: 47: 1022-1031.

  23. Guadalajara JF, Martínez SC, Gutiérrez PE, Zamora C, Huerta D: Estudio de la función ventricular mediante la cuantificación de la relación grosor/radio (h/r) del ventrículo izquierdo en sujetos sanos. Arch Inst Cardiol Mex 1989; 59: 293-300.

  24. Shah P: Echocardiography in congestive or dilated cardiomyopathy. J Am Soc Echocard 1988; 1: 20-30.

  25. Benjamín IJ, Schuster EH, Bulkley BH: Cardiac hypertrophy in dilated congestive cardiomyopathy: A clinic or pathologic study. Circulation 1981; 64: 442-447.

  26. Bargiggia GS, Bertucci C, Recusani F, Raisars A, de Servi SA, Valdes-Cruz LM, et al: A new method for stimating left ventricular dP/dT by continuous wave Doppler echocardiography. Circulation 1989; 80: 1287-1292.

  27. Kolias JT, Aaronson KD, Armstrong WF: Doppler-Derived dP/dT and dp/dt and predict survival in congestive heart failure. J Am Coll Cardiol 2000; 36: 1594-1599.

  28. Rihal CS, Nishimura RA, Hatle LK, Bailey KR, Tajik AJ: Systolic and diastolic dysfunction in patients with clinical diagnosis of dilated cardiomyopathy: relation to symptoms and prognosis. Circulation 1994; 90: 2772-9.

  29. Thomas JD, Weyman AE: Echocardiographic Doppler evaluation of left ventricular diastolic function. Physics and physiology. Circulation 1991; 84: 977-990.

  30. Pinamonti B, Lenarda A, Sinagra G, Camerini F: Restrictive left ventricular filling pattern in dilated cardiomyopathy assessed by Doppler echocardiography: clinical, echocardiographic and hemodynamic correlations and prognostic implications. J Am Coll Cardiol 1993; 22: 808-815.

  31. Gong-Yuan Xic, Berk MR, Smith MD, Gurley JC, DeMaria AN: Prognostic value of Doppler transmitral flow patterns in patients with congestive heart failure. J Am Coll Cardiol 1994; 24: 132-139.

  32. Smith RH, Lazar JM, Hirsch HI, Macina G, Steingart RM: Restrictive transmitral filling pattern in CHF: relation to hospital readmission. J Am Soc Echocard 1997; 10: 423.

  33. Lee DCh, Oh JK, Osborn SL, Mahoney DW, Seward JB: Repeat evaluation of diastolic filling pattern after treatment of congestive heart failure in patients with restrictive diastolic filling: implications for long term prognosis. J Am Soc Echocardio 1997; 10: 431.

  34. Quiñones M, Greemberg BH, Kopelen HA, Koipillai C, Limacher MC, Shindler DM, et al: Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in SOLVD register and trials: significance of left ventricular hypertrophy. J Am Coll Cardiol 2000; 35: 1237-1244.

  35. Cintron G, Francis G, Cobe F, Cohn J: Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. Circulation 1993; 87(Suppl VI): 17-23.

  36. Levin HR, Oz MC, Chen JM, Packer M, Rose EA, Burkhoff D: Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. Circulation 1995; 91: 2717-2720.

  37. Rose EA, Geliigs AC, Moskowitz AJ, Heitdan DF, Stevenson LW, Dembitzky W, et al: Long term use of left ventricular assist device for end-stage heart failure. N Engl J Med 2001; 345: 1435-1443.

  38. Hosenpud JD, Bennett LE, Keck BM, Fiol B, Bouce KMM, Novick RJ: The registry of the International Society for Heart and Lung Transplantation: sixteenth official report-1999. J Heart Lung Transplant 1999; 18: 611-626.




2020     |     www.medigraphic.com